for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Cipla Ltd

CIPL.NS

Latest Trade

444.15INR

Change

-2.15(-0.48%)

Volume

2,850,227

Today's Range

440.10

 - 

451.15

52 Week Range

389.55

 - 

645.55

As of on the National Stock Exchange of India ∙ Minimum 15 minute delay

Latest Developments

Venus Remedies Announces Sale Of Elores To Cipla In India

Oct 17 (Reuters) - Cipla Ltd <CIPL.NS>::VENUS REMEDIES LTD - ANNOUNCES SALE OF ELORES TO CIPLA IN INDIA.

Cipla Announces Launch Of Daptomycin For Injection

Sept 25 (Reuters) - Cipla Ltd <CIPL.NS>::CIPLA LTD - ANNOUNCES LAUNCH OF DAPTOMYCIN FOR INJECTION, 500 MG/VIAL, SINGLE-DOSE VIALS.

Cipla To Buy Stake Of Eight Roads Investment Mauritius II In Unit Cipla Health

Aug 7 (Reuters) - Cipla Ltd <CIPL.NS>::SIGNED DEFINITIVE DEAL TO BUY MINORITY STAKE OF EIGHT ROADS INVESTMENT MAURITIUS II IN UNIT CIPLA HEALTH.DEAL FOR 3.50 BILLION RUPEES.

India's Cipla June Qtr Consol Net Profit Attributable Rises

Aug 7 (Reuters) - Cipla Ltd <CIPL.NS>::JUNE QUARTER CONSOL NET PROFIT ATTRIBUTABLE 4.78 BILLION RUPEES VERSUS 4.51 BILLION RUPEES LAST YEAR.CONSENSUS FORECAST FOR JUNE QUARTER CONSOL NET PROFIT WAS 4.96 BILLION RUPEES.JUNE QUARTER CONSOL NET SALES 38.94 BILLION RUPEES VERSUS 38.46 BILLION RUPEES LAST YEAR.

Indian Pharma Firms Sent Notices By Govt Body For Introducing Drugs Without Approval

July 23 (Reuters) - :INDIAN COS INTRODUCING 22 DRUGS WITHOUT PRIOR APPROVAL OF THE NATIONAL PHARMACEUTICAL PRICING AUTHORITY HAVE BEEN ISSUED NOTICES - GOVERNMENT STATEMENT.NPPA HAS SO FAR ISSUED DEMAND NOTICES FOR AN AMOUNT OF 1.01 BILLION RUPEES AGAINST DEFAULTING COMPANIES - GOVERNMENT STATEMENT.INDIAN COMPANIES ISSUED NOTICES BY NPPA INCLUDE ALEMBIC PHARMA, BIOCON LTD, CIPLA, LUPIN, WOCKHARDT, SANOFI INDIA, DR REDDYS LABS - GOVERNMENT.

FDA Approves First Generics Of Lyrica

July 22 (Reuters) - U.S. Food and Drug Administration::FDA APPROVES FIRST GENERICS OF LYRICA.U.S. FOOD AND DRUG ADMINISTRATION SAYS ON JULY 19, FDA APPROVED MULTIPLE APPLICATIONS FOR FIRST GENERICS OF LYRICA (PREGABALIN).U.S. FDA SAYS GRANTED APPROVALS FOR GENERIC VERSIONS OF LYRICA TO ALKEM LABORATORIES, DR. REDDY'S LABORATORIES, INVAGEN PHARMACEUTICALS.U.S. FDA SAYS ALSO GRANTED APPROVALS FOR GENERIC VERSIONS OF LYRICA TO MSN LABORATORIES LTD, SCIEGEN PHARMACEUTICALS INC, AND TEVA PHARMACEUTICALS.

Cipla To Buy 26% Stake In AMPSolar Power Systems For Up To 129 Mln Rupees

May 23 (Reuters) - Cipla Ltd <CIPL.NS>::SIGNED AGREEMENT TO ACQUIRE 26% STAKE ON A FULLY DILUTED BASIS IN AMPSOLAR POWER SYSTEMS PRIVATE LIMITED.DEAL FOR UP TO 129 MILLION RUPEES.

India's Cipla March Qtr Consol Net Profit Falls

May 22 (Reuters) - Cipla Ltd <CIPL.NS>::MARCH QUARTER CONSOL NET PROFIT 3.67 BILLION RUPEES VERSUS 1.79 BILLION RUPEES LAST YEAR.CONSENSUS FORECAST FOR MARCH QUARTER CONSOL NET PROFIT WAS 30.89 BILLION RUPEES.MARCH QUARTER CONSOL NET SALES 42.71 BILLION RUPEES VERSUS 34.96 BILLION RUPEES LAST YEAR.RECOMMENDED DIVIDEND OF 3 RUPEES PER SHARE.

Cipla Gets Final ANDA Approval For Ambrisentan Tablets From USFDA

April 30 (Reuters) - Cipla Ltd <CIPL.NS>::CIPLA SAYS GOT FINAL ANDA APPROVAL FOR AMBRISENTAN TABLETS 5MG & 10MG FROM USFDA.

Cipla Gets EIR From USFDA For Goa Plant

April 4 (Reuters) - Cipla Ltd <CIPL.NS>::GETS ESTABLISHMENT INSPECTION REPORT FROM USFDA FOR GOA PLANT.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up